Beam Therapeutics Stock (NASDAQ: BEAM) stock price, news, charts, stock research, profile.
Open | $25.81 |
Close | - |
Volume / Avg. | 380.55K / 1.09M |
Day Range | $24.47 - $25.83 |
52 Wk Range | 16.95 - 49.50 |
Market Cap | $2.04B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 17.61% |
Days to Cover | 16.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.
Other companies in Beam Therapeutics’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX), Arrowhead Pharma (NASDAQ:ARWR), Agios Pharmaceuticals (NASDAQ:AGIO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Beam Therapeutics has a consensus price target of $60.65.
The stock price for Beam Therapeutics (NASDAQ: BEAM) is $25.83 last updated September 23, 2024 at 9:30 AM EDT.
A quarterly cash dividend of 0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.
Beam Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Beam Therapeutics.
Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.